Research

A new drug for Alzheimer's could reach the market in 2023

28/09/2022
The pharmaceutical companies Eisai and Biogen have just announced to the press the results of their monoclonal antibody Lecanemab, a drug targeted at the deposit of amyloid in the brain.

The rules for the 1st edition of the Lluís Tárraga Award have been published

06/07/2022Training
The winner of the award will receive financial compensation of €1,000 and will have the opportunity to carry out a public event promoted by Ace with the aim of disseminating the work.

More than 300 people attend the XII edition of the Barcelona-Pittsburgh conference

09/06/2022Training
After two years of pandemic and two postponements, the XII edition of the Barcelona-Pittsburgh biennial conference took place between 1st and 3rd June in Barcelona.

Registrations open for the webinar "Advances in Molecular Neuroimaging"

26/04/2021Training
Ace Alzheimer Center Barcelona and Grifols, with the participation of Kern Pharma, promote a conference cycle named "Global Research Summit”, a series of free webinars directed towards professionals in the field of dementia.

More than 60 caregivers participate in an online session on therapeutic exercise

25/03/2021Training
Marta Bisbe, coordinator of the Fundación ACE’s Physiotherapy Unit, and Roger Arbós, physiotherapist of the Day Care Unit, explained to more than 60 caregivers and family members of users of the Day Care Unit the benefits of therapeutic exercise.

Carla Abdelnour, speaker at the XVIII annual meeting of the Madrid Neurology Association

22/10/2020Training
Dr. Carla Abdelnour, neurologist and member of the Fundació ACE clinical trials team, participates in the XVIII annual meeting of the AMN (Madrid Neurology Association) with a presentation entitled "Clinical aspects of dementia with Lewy bodies"